Development and delivery of a pharmacist training program to increase naloxone access in Kentucky

Abstract Objective To describe the development and delivery of a comprehensive training program for Kentucky pharmacists to enable dispensation of naloxone per protocol. Practice description In May 2015, the Kentucky Board of Pharmacy (KBP) promulgated regulations outlining the requirements for phar...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American Pharmacists Association 2017-03, Vol.57 (2), p.S118-S122
Hauptverfasser: Palmer, Emma, Hart, Steve, Freeman, Patricia R
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page S122
container_issue 2
container_start_page S118
container_title Journal of the American Pharmacists Association
container_volume 57
creator Palmer, Emma
Hart, Steve
Freeman, Patricia R
description Abstract Objective To describe the development and delivery of a comprehensive training program for Kentucky pharmacists to enable dispensation of naloxone per protocol. Practice description In May 2015, the Kentucky Board of Pharmacy (KBP) promulgated regulations outlining the requirements for pharmacists to initiate the dispensing of naloxone under a physician-approved protocol. The Advancing Pharmacy Practice in Kentucky Coalition, a partnership between Kentucky’s Colleges of Pharmacy, KBP, and state and local pharmacists associations, developed and offered educational programming to fulfill this regulation. Pharmacists who completed the 90-minute program could apply to KBP for registration as a naloxone-certified pharmacist. The program consists of a 90-minute session covering naloxone access, opioid overdoses, the pharmacology and use of naloxone, protocol development, patient identification, and resources. Sessions were offered live and via webinar. Sessions have also been incorporated into the pharmacy curriculum at the 2 colleges of pharmacy in Kentucky. Results Between June 28, 2015, and June 1, 2016, a total of 1254 pharmacists and 348 student pharmacists completed training. Of those, 646 (52%) have applied to KBP and received naloxone-certified status. The program was well received, with 87% of learners ranking the usefulness of the information presented as excellent. Learners cited screening tips, protocol information, patient screening information, and education resources as information they will implement in their practice. Conclusion The swift deployment of training to a wide variety of pharmacy professionals has resulted in a substantial number of naloxone-certified pharmacists across Kentucky. Through a coordinated training initiative involving all major pharmacy stakeholders, we reached many individuals rapidly, documenting the value of this approach for future training endeavors. This educational initiative may enhance pharmacy practice across Kentucky and the nation by expanding and educating on the role pharmacists can play in public health and overdose death prevention.
doi_str_mv 10.1016/j.japh.2016.12.071
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1865517932</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1544319116310111</els_id><sourcerecordid>1865517932</sourcerecordid><originalsourceid>FETCH-LOGICAL-c455t-d4c837c9c2823b9c0e4ce2bb72ac64d26c98a24e3d4a71b63277cf65f5d656793</originalsourceid><addsrcrecordid>eNp9kc1u1TAQhS0EoqXwAiyQl2xusJ3ESSSEhFr-RKUuCmtrMp60TpM42MlV79vj6LYsWHQ1I805RzPfMPZWikwKqT_0WQ_zbaZSn0mViUo-Y6eyLIpdXpTi-WMvG3nCXsXYC6Eq3dQv2YmqpZa5EKcMLmhPg59HmhYOk-WWBrencOC-48DnWwgjoIsLXwK4yU03fA7-JsDIF8_dhIEgEp9g8Pd-Ig6IFGMa8J8pccW7w2v2ooMh0puHesZ-f_3y6_z77vLq24_zz5c7LMpy2dkC67zCBlWt8rZBQQWSattKAerCKo1NDaqg3BZQyVbnqqqw02VXWl3qqsnP2Ptjbtrvz0pxMaOLSMMAE_k1GlnrspRJqJJUHaUYfIyBOjMHN0I4GCnMhtb0ZkNrNrRGKpPQJtO7h_y1Hcn-szyyTIKPRwGlK_eOgonoaEKyLhAuxnr3dP6n_-w4JOAIwx0dKPZ-DYlyusPEZDDX23O330qdp0gp87-4YZ_p</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1865517932</pqid></control><display><type>article</type><title>Development and delivery of a pharmacist training program to increase naloxone access in Kentucky</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Palmer, Emma ; Hart, Steve ; Freeman, Patricia R</creator><creatorcontrib>Palmer, Emma ; Hart, Steve ; Freeman, Patricia R</creatorcontrib><description>Abstract Objective To describe the development and delivery of a comprehensive training program for Kentucky pharmacists to enable dispensation of naloxone per protocol. Practice description In May 2015, the Kentucky Board of Pharmacy (KBP) promulgated regulations outlining the requirements for pharmacists to initiate the dispensing of naloxone under a physician-approved protocol. The Advancing Pharmacy Practice in Kentucky Coalition, a partnership between Kentucky’s Colleges of Pharmacy, KBP, and state and local pharmacists associations, developed and offered educational programming to fulfill this regulation. Pharmacists who completed the 90-minute program could apply to KBP for registration as a naloxone-certified pharmacist. The program consists of a 90-minute session covering naloxone access, opioid overdoses, the pharmacology and use of naloxone, protocol development, patient identification, and resources. Sessions were offered live and via webinar. Sessions have also been incorporated into the pharmacy curriculum at the 2 colleges of pharmacy in Kentucky. Results Between June 28, 2015, and June 1, 2016, a total of 1254 pharmacists and 348 student pharmacists completed training. Of those, 646 (52%) have applied to KBP and received naloxone-certified status. The program was well received, with 87% of learners ranking the usefulness of the information presented as excellent. Learners cited screening tips, protocol information, patient screening information, and education resources as information they will implement in their practice. Conclusion The swift deployment of training to a wide variety of pharmacy professionals has resulted in a substantial number of naloxone-certified pharmacists across Kentucky. Through a coordinated training initiative involving all major pharmacy stakeholders, we reached many individuals rapidly, documenting the value of this approach for future training endeavors. This educational initiative may enhance pharmacy practice across Kentucky and the nation by expanding and educating on the role pharmacists can play in public health and overdose death prevention.</description><identifier>ISSN: 1544-3191</identifier><identifier>EISSN: 1544-3450</identifier><identifier>DOI: 10.1016/j.japh.2016.12.071</identifier><identifier>PMID: 28161300</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject><![CDATA[Analgesics, Opioid - adverse effects ; Certification ; Curriculum ; Drug Overdose - drug therapy ; Education, Pharmacy - methods ; Education, Pharmacy, Continuing - methods ; Health Services Accessibility ; Humans ; Internal Medicine ; Kentucky ; Naloxone - administration & dosage ; Naloxone - supply & distribution ; Narcotic Antagonists - administration & dosage ; Narcotic Antagonists - supply & distribution ; Opioid-Related Disorders - complications ; Opioid-Related Disorders - drug therapy ; Pharmaceutical Services - organization & administration ; Pharmacists - organization & administration ; Professional Role ; Students, Pharmacy]]></subject><ispartof>Journal of the American Pharmacists Association, 2017-03, Vol.57 (2), p.S118-S122</ispartof><rights>American Pharmacists Association</rights><rights>2017 American Pharmacists Association</rights><rights>Copyright © 2017 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c455t-d4c837c9c2823b9c0e4ce2bb72ac64d26c98a24e3d4a71b63277cf65f5d656793</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28161300$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Palmer, Emma</creatorcontrib><creatorcontrib>Hart, Steve</creatorcontrib><creatorcontrib>Freeman, Patricia R</creatorcontrib><title>Development and delivery of a pharmacist training program to increase naloxone access in Kentucky</title><title>Journal of the American Pharmacists Association</title><addtitle>J Am Pharm Assoc (2003)</addtitle><description>Abstract Objective To describe the development and delivery of a comprehensive training program for Kentucky pharmacists to enable dispensation of naloxone per protocol. Practice description In May 2015, the Kentucky Board of Pharmacy (KBP) promulgated regulations outlining the requirements for pharmacists to initiate the dispensing of naloxone under a physician-approved protocol. The Advancing Pharmacy Practice in Kentucky Coalition, a partnership between Kentucky’s Colleges of Pharmacy, KBP, and state and local pharmacists associations, developed and offered educational programming to fulfill this regulation. Pharmacists who completed the 90-minute program could apply to KBP for registration as a naloxone-certified pharmacist. The program consists of a 90-minute session covering naloxone access, opioid overdoses, the pharmacology and use of naloxone, protocol development, patient identification, and resources. Sessions were offered live and via webinar. Sessions have also been incorporated into the pharmacy curriculum at the 2 colleges of pharmacy in Kentucky. Results Between June 28, 2015, and June 1, 2016, a total of 1254 pharmacists and 348 student pharmacists completed training. Of those, 646 (52%) have applied to KBP and received naloxone-certified status. The program was well received, with 87% of learners ranking the usefulness of the information presented as excellent. Learners cited screening tips, protocol information, patient screening information, and education resources as information they will implement in their practice. Conclusion The swift deployment of training to a wide variety of pharmacy professionals has resulted in a substantial number of naloxone-certified pharmacists across Kentucky. Through a coordinated training initiative involving all major pharmacy stakeholders, we reached many individuals rapidly, documenting the value of this approach for future training endeavors. This educational initiative may enhance pharmacy practice across Kentucky and the nation by expanding and educating on the role pharmacists can play in public health and overdose death prevention.</description><subject>Analgesics, Opioid - adverse effects</subject><subject>Certification</subject><subject>Curriculum</subject><subject>Drug Overdose - drug therapy</subject><subject>Education, Pharmacy - methods</subject><subject>Education, Pharmacy, Continuing - methods</subject><subject>Health Services Accessibility</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Kentucky</subject><subject>Naloxone - administration &amp; dosage</subject><subject>Naloxone - supply &amp; distribution</subject><subject>Narcotic Antagonists - administration &amp; dosage</subject><subject>Narcotic Antagonists - supply &amp; distribution</subject><subject>Opioid-Related Disorders - complications</subject><subject>Opioid-Related Disorders - drug therapy</subject><subject>Pharmaceutical Services - organization &amp; administration</subject><subject>Pharmacists - organization &amp; administration</subject><subject>Professional Role</subject><subject>Students, Pharmacy</subject><issn>1544-3191</issn><issn>1544-3450</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc1u1TAQhS0EoqXwAiyQl2xusJ3ESSSEhFr-RKUuCmtrMp60TpM42MlV79vj6LYsWHQ1I805RzPfMPZWikwKqT_0WQ_zbaZSn0mViUo-Y6eyLIpdXpTi-WMvG3nCXsXYC6Eq3dQv2YmqpZa5EKcMLmhPg59HmhYOk-WWBrencOC-48DnWwgjoIsLXwK4yU03fA7-JsDIF8_dhIEgEp9g8Pd-Ig6IFGMa8J8pccW7w2v2ooMh0puHesZ-f_3y6_z77vLq24_zz5c7LMpy2dkC67zCBlWt8rZBQQWSattKAerCKo1NDaqg3BZQyVbnqqqw02VXWl3qqsnP2Ptjbtrvz0pxMaOLSMMAE_k1GlnrspRJqJJUHaUYfIyBOjMHN0I4GCnMhtb0ZkNrNrRGKpPQJtO7h_y1Hcn-szyyTIKPRwGlK_eOgonoaEKyLhAuxnr3dP6n_-w4JOAIwx0dKPZ-DYlyusPEZDDX23O330qdp0gp87-4YZ_p</recordid><startdate>20170301</startdate><enddate>20170301</enddate><creator>Palmer, Emma</creator><creator>Hart, Steve</creator><creator>Freeman, Patricia R</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20170301</creationdate><title>Development and delivery of a pharmacist training program to increase naloxone access in Kentucky</title><author>Palmer, Emma ; Hart, Steve ; Freeman, Patricia R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c455t-d4c837c9c2823b9c0e4ce2bb72ac64d26c98a24e3d4a71b63277cf65f5d656793</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Analgesics, Opioid - adverse effects</topic><topic>Certification</topic><topic>Curriculum</topic><topic>Drug Overdose - drug therapy</topic><topic>Education, Pharmacy - methods</topic><topic>Education, Pharmacy, Continuing - methods</topic><topic>Health Services Accessibility</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Kentucky</topic><topic>Naloxone - administration &amp; dosage</topic><topic>Naloxone - supply &amp; distribution</topic><topic>Narcotic Antagonists - administration &amp; dosage</topic><topic>Narcotic Antagonists - supply &amp; distribution</topic><topic>Opioid-Related Disorders - complications</topic><topic>Opioid-Related Disorders - drug therapy</topic><topic>Pharmaceutical Services - organization &amp; administration</topic><topic>Pharmacists - organization &amp; administration</topic><topic>Professional Role</topic><topic>Students, Pharmacy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Palmer, Emma</creatorcontrib><creatorcontrib>Hart, Steve</creatorcontrib><creatorcontrib>Freeman, Patricia R</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American Pharmacists Association</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Palmer, Emma</au><au>Hart, Steve</au><au>Freeman, Patricia R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development and delivery of a pharmacist training program to increase naloxone access in Kentucky</atitle><jtitle>Journal of the American Pharmacists Association</jtitle><addtitle>J Am Pharm Assoc (2003)</addtitle><date>2017-03-01</date><risdate>2017</risdate><volume>57</volume><issue>2</issue><spage>S118</spage><epage>S122</epage><pages>S118-S122</pages><issn>1544-3191</issn><eissn>1544-3450</eissn><abstract>Abstract Objective To describe the development and delivery of a comprehensive training program for Kentucky pharmacists to enable dispensation of naloxone per protocol. Practice description In May 2015, the Kentucky Board of Pharmacy (KBP) promulgated regulations outlining the requirements for pharmacists to initiate the dispensing of naloxone under a physician-approved protocol. The Advancing Pharmacy Practice in Kentucky Coalition, a partnership between Kentucky’s Colleges of Pharmacy, KBP, and state and local pharmacists associations, developed and offered educational programming to fulfill this regulation. Pharmacists who completed the 90-minute program could apply to KBP for registration as a naloxone-certified pharmacist. The program consists of a 90-minute session covering naloxone access, opioid overdoses, the pharmacology and use of naloxone, protocol development, patient identification, and resources. Sessions were offered live and via webinar. Sessions have also been incorporated into the pharmacy curriculum at the 2 colleges of pharmacy in Kentucky. Results Between June 28, 2015, and June 1, 2016, a total of 1254 pharmacists and 348 student pharmacists completed training. Of those, 646 (52%) have applied to KBP and received naloxone-certified status. The program was well received, with 87% of learners ranking the usefulness of the information presented as excellent. Learners cited screening tips, protocol information, patient screening information, and education resources as information they will implement in their practice. Conclusion The swift deployment of training to a wide variety of pharmacy professionals has resulted in a substantial number of naloxone-certified pharmacists across Kentucky. Through a coordinated training initiative involving all major pharmacy stakeholders, we reached many individuals rapidly, documenting the value of this approach for future training endeavors. This educational initiative may enhance pharmacy practice across Kentucky and the nation by expanding and educating on the role pharmacists can play in public health and overdose death prevention.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>28161300</pmid><doi>10.1016/j.japh.2016.12.071</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1544-3191
ispartof Journal of the American Pharmacists Association, 2017-03, Vol.57 (2), p.S118-S122
issn 1544-3191
1544-3450
language eng
recordid cdi_proquest_miscellaneous_1865517932
source MEDLINE; Alma/SFX Local Collection
subjects Analgesics, Opioid - adverse effects
Certification
Curriculum
Drug Overdose - drug therapy
Education, Pharmacy - methods
Education, Pharmacy, Continuing - methods
Health Services Accessibility
Humans
Internal Medicine
Kentucky
Naloxone - administration & dosage
Naloxone - supply & distribution
Narcotic Antagonists - administration & dosage
Narcotic Antagonists - supply & distribution
Opioid-Related Disorders - complications
Opioid-Related Disorders - drug therapy
Pharmaceutical Services - organization & administration
Pharmacists - organization & administration
Professional Role
Students, Pharmacy
title Development and delivery of a pharmacist training program to increase naloxone access in Kentucky
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T13%3A31%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20and%20delivery%20of%20a%20pharmacist%20training%20program%20to%20increase%20naloxone%20access%20in%20Kentucky&rft.jtitle=Journal%20of%20the%20American%20Pharmacists%20Association&rft.au=Palmer,%20Emma&rft.date=2017-03-01&rft.volume=57&rft.issue=2&rft.spage=S118&rft.epage=S122&rft.pages=S118-S122&rft.issn=1544-3191&rft.eissn=1544-3450&rft_id=info:doi/10.1016/j.japh.2016.12.071&rft_dat=%3Cproquest_cross%3E1865517932%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1865517932&rft_id=info:pmid/28161300&rft_els_id=S1544319116310111&rfr_iscdi=true